Detalhe da pesquisa
1.
Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.
Infect Immun
; 89(9): e0021721, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228490
2.
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
N Engl J Med
; 374(18): 1723-32, 2016 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27144848
3.
Vibrio cholerae Isolation from Frozen Vomitus and Stool Samples.
J Clin Microbiol
; 60(10): e0108422, 2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169311
4.
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
Lancet
; 386(10001): 1362-1371, 2015 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26164097
5.
Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.
Infect Immun
; 83(3): 1089-103, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25561705
6.
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
Cochrane Database Syst Rev
; (7): CD009029, 2013 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23828581
7.
Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.
Am J Trop Med Hyg
; 109(5): 1122-1128, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783453
8.
Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden setting.
bioRxiv
; 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205407
9.
Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.
mSphere
; 8(5): e0025523, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646517
10.
Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study.
Lancet Microbe
; 4(4): e228-e235, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36907197
11.
LPLUNC1 modulates innate immune responses to Vibrio cholerae.
J Infect Dis
; 204(9): 1349-57, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900486
12.
Virus-like Particle Display of Vibrio choleraeO-Specific Polysaccharide as a Potential Vaccine against Cholera.
ACS Infect Dis
; 8(3): 574-583, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170309
13.
Mucosal-Associated Invariant T (MAIT) cells are highly activated in duodenal tissue of humans with Vibrio cholerae O1 infection: A preliminary report.
PLoS Negl Trop Dis
; 16(5): e0010411, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551522
14.
Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay.
mBio
; 13(6): e0190022, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286520
15.
A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients.
mSystems
; 6(4): e0088921, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427503
16.
Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine.
Am J Trop Med Hyg
; 104(6): 2024-2030, 2021 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872211
17.
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
mSphere
; 6(4): e0011421, 2021 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232076
18.
Scalable production and immunogenicity of a cholera conjugate vaccine.
Vaccine
; 39(47): 6936-6946, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716040
19.
Evaluation of a Rapid Point-of-Care Multiplex Immunochromatographic Assay for the Diagnosis of Enteric Fever.
mSphere
; 5(3)2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522777
20.
HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
BMJ Open
; 10(1): e033702, 2020 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959609